The Food and Drug Administration (FDA) has approved Restasis for treating chronic dry eye in adults and children ages 16 years and older. It’s available in single-use vials and a multiuse bottle.

Both Xiidra and Restasis are prescription medications approved by the FDA to treat dry eye disease. They contain different active ingredients: lifitegrast in Xiidra and cyclosporine in Restasis.

If you have chronic (long-term) dry eye, your doctor might suggest treatment with Xiidra or Restasis. They’re both prescription medications prescribed to treat chronic dry eye (also called dry eye ...

Restasis (cyclosporine) eye drops can cause side effects that range from mild to serious. Common side effects of Restasis include blurry vision, eye discharge, and painful or burning sensations in the ...